FDA denies generic drug fluvoxamine emergency use authorization as COVID treatment
The Food and Drug Administration (FDA) has rejected a request to grant emergency use authorization to a cheap generic drug for the treatment of Wuhan coronavirus (COVID-19). This decision has sparked controversy and drawn criticism from many healthcare workers. The drug in question is fluvoxamine, …
Read More